{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:28:35Z","timestamp":1790958515833,"version":"4.1.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dongguan City University and Urban Integration Development Research Center","award":["2024KF010"],"award-info":[{"award-number":["2024KF010"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>This study presents a targeted virtual drug screening approach for autism spectrum disorder (ASD), focusing on Cav1.2 calcium ion channels as potential therapeutic targets. ASD is a complex neurodevelopmental disorder characterized by impairments in social communication and behavior, with genetic factors playing a significant role. Cav1.2 channels have been implicated in the pathophysiology of ASD due to their role in regulating neuronal excitability and synaptic transmission. We employed computational methods to virtually screen a large database of compounds for their potential to modulate Cav1.2 channel function. Molecular docking simulations were used to identify potential Cav1.2 inhibitors, followed by pharmacokinetic modeling to assess drug-like properties. Molecular dynamics (MD) simulations were performed to evaluate the interactions of the top candidates with Cav1.2, and Molecular Mechanics\/Poisson-Boltzmann Surface Area (MM\/PBSA) analysis was employed to predict binding free energies. This approach identified several promising drug candidates, including ZINC000828320609, which exhibited strong binding affinity to Cav1.2, favorable pharmacokinetic properties, and no predicted toxicity. The virtual screening results provide a solid foundation for further experimental validation and potential drug development for ASD, offering a novel and efficient strategy to target Cav1.2 channels in the treatment of this complex disorder.<\/jats:p>","DOI":"10.1371\/journal.pone.0324018","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T13:28:42Z","timestamp":1748525322000},"page":"e0324018","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeted drug screening for autism based on Cav1.2 calcium ion channel"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7432-3345","authenticated-orcid":true,"given":"Chao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"issue":"1","key":"pone.0324018.ref001","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s13311-022-01183-1","article-title":"An update on psychopharmacological treatment of autism spectrum disorder","volume":"19","author":"R Aishworiya","year":"2022","journal-title":"Neurotherapeutics"},{"key":"pone.0324018.ref002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ridd.2020.103822","article-title":"Stress and emotional wellbeing of parents due to change in routine for children with autism spectrum disorder (ASD) at home during COVID-19 pandemic in Saudi Arabia","volume":"108","author":"T Alhuzimi","year":"2021","journal-title":"Res Dev Disabil"},{"issue":"10","key":"pone.0324018.ref003","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.tins.2021.08.005","article-title":"Hippocampal contributions to social and cognitive deficits in autism spectrum disorder","volume":"44","author":"SM Banker","year":"2021","journal-title":"Trends Neurosci"},{"issue":"4","key":"pone.0324018.ref004","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41431-019-0524-0","article-title":"A de novo splicing variant supports the candidacy of TLL1 in ASD pathogenesis","volume":"28","author":"T Alanzi","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"pone.0324018.ref005","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1101422","article-title":"RNA epitranscriptomics dysregulation: a major determinant for significantly increased risk of ASD pathogenesis","volume":"17","author":"A Beopoulos","year":"2023","journal-title":"Front Neurosci"},{"issue":"3","key":"pone.0324018.ref006","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"W L\u00f6scher","year":"2020","journal-title":"Pharmacol Rev"},{"issue":"1","key":"pone.0324018.ref007","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/10717544.2019.1704940","article-title":"Mechanisms of increased bioavailability through amorphous solid dispersions: a review","volume":"27","author":"A Schittny","year":"2020","journal-title":"Drug Deliv"},{"key":"pone.0324018.ref008","doi-asserted-by":"crossref","first-page":"107776","DOI":"10.1016\/j.jmgm.2020.107776","article-title":"Effects of selective calcium channel blockers on ions\u2019 permeation through the human Cav1.2 ion channel: A computational study","volume":"102","author":"FES Mosa","year":"2021","journal-title":"J Mol Graph Model"},{"issue":"14","key":"pone.0324018.ref009","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2221242120","article-title":"Acute phosphatidylinositol 4,5 bisphosphate depletion destabilizes sarcolemmal expression of cardiac L-type Ca2 channel CaV1.2","volume":"120","author":"T Voelker","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0324018.ref010","doi-asserted-by":"crossref","first-page":"176289","DOI":"10.1016\/j.ejphar.2023.176289","article-title":"Anti-diarrheal effect of piperine possibly through the interaction with inflammation inducing enzymes: In vivo and in silico studies","volume":"965","author":"M Afroz","year":"2024","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"pone.0324018.ref011","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/CIRCRESAHA.120.316710","article-title":"Atrial Myocyte NLRP3\/CaMKII Nexus Forms a Substrate for Postoperative Atrial Fibrillation","volume":"127","author":"J Heijman","year":"2020","journal-title":"Circ Res"},{"issue":"7","key":"pone.0324018.ref012","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41587-022-01561-2","article-title":"A genetically encoded sensor measures temporal oxytocin release from different neuronal compartments","volume":"41","author":"T Qian","year":"2023","journal-title":"Nat Biotechnol"},{"issue":"1","key":"pone.0324018.ref013","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41467-023-36209-5","article-title":"Astrocytic lactate dehydrogenase A regulates neuronal excitability and depressive-like behaviors through lactate homeostasis in mice","volume":"14","author":"S Yao","year":"2023","journal-title":"Nat Commun"},{"key":"pone.0324018.ref014","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-neuro-092920-121538","article-title":"Ion Channel Degeneracy, Variability, and Covariation in Neuron and Circuit Resilience","volume":"44","author":"JM Goaillard","year":"2021","journal-title":"Annu Rev Neurosci"},{"key":"pone.0324018.ref015","article-title":"Post-translational modification of Cav1.2 and its role in neurodegenerative diseases","volume":"12","author":"Y Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"pone.0324018.ref016","first-page":"15","article-title":"Involvement of calcium-dependent pathway and \u03b2 subunit-interaction in neuronal migration and callosal projection deficits caused by the Cav1.2 I1166T mutation in developing mouse neocortex","author":"N Nakagawa-Tamagawa","year":"2021","journal-title":"Front Neurosci"},{"key":"pone.0324018.ref017","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.omtn.2023.02.019","article-title":"Artificial intelligence for drug discovery: Resources, methods, and applications","volume":"31","author":"W Chen","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"pone.0324018.ref018","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.sbi.2021.09.003","article-title":"Toward better drug discovery with knowledge graph","volume":"72","author":"X Zeng","year":"2022","journal-title":"Curr Opin Struct Biol"},{"key":"pone.0324018.ref019","article-title":"Discovering anti-cancer drugs via computational methods","volume":"11","author":"W Cui","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"pone.0324018.ref020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295629","article-title":"Integrated drug response prediction models pinpoint repurposed drugs with effectiveness against rhabdomyosarcoma","volume":"19","author":"B Baek","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"pone.0324018.ref021","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/0929867327666200128111925","article-title":"Web-based Tools for Drug Repurposing: Successful Examples of Collaborative Research","volume":"28","author":"Q Vanhaelen","year":"2021","journal-title":"Curr Med Chem"},{"issue":"6","key":"pone.0324018.ref022","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061573","article-title":"A gene co-expression network-based drug repositioning approach identifies candidates for treatment of hepatocellular carcinoma","volume":"14","author":"M Yuan","year":"2022","journal-title":"Cancers"},{"key":"pone.0324018.ref023","doi-asserted-by":"crossref","first-page":"101709","DOI":"10.1016\/j.frl.2020.101709","article-title":"Infectious disease pandemic and permanent volatility of international stock markets: A long-term perspective","volume":"40","author":"L Bai","year":"2021","journal-title":"Financ Res Lett"},{"key":"pone.0324018.ref024","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.715759","article-title":"Emerging and re-emerging vector-borne infectious diseases and the challenges for control: A review","volume":"9","author":"B Chala","year":"2021","journal-title":"Front Public Health"},{"issue":"2","key":"pone.0324018.ref025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0042098020910873","article-title":"Extended urbanisation and the spatialities of infectious disease: Demographic change, infrastructure and governance","volume":"58","author":"C Connolly","year":"2020","journal-title":"Urban Studies"},{"issue":"5","key":"pone.0324018.ref026","article-title":"Drug design by pharmacophore and virtual screening approach","volume":"15","author":"D Giordano","year":"2022","journal-title":"Pharmaceutics"},{"issue":"13","key":"pone.0324018.ref027","article-title":"A loop-based and AGO-incorporated virtual screening model targeting AGO-mediated miRNA-mRNA interactions for drug discovery to rescue bone phenotype in genetically modified mice","volume":"7","author":"ZJ Zhuo","year":"2020","journal-title":"Adv Sci"},{"issue":"8","key":"pone.0324018.ref028","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1080\/07391102.2020.1758791","article-title":"Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes","volume":"39","author":"AD Elmezayen","year":"2021","journal-title":"J Biomol Struct Dyn"},{"issue":"6","key":"pone.0324018.ref029","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1021\/acs.jcim.0c00179","article-title":"Fast identification of possible drug treatment of coronavirus disease-19 (COVID-19) through computational drug repurposing study","volume":"60","author":"J Wang","year":"2020","journal-title":"J Chem Inf Model"},{"issue":"2","key":"pone.0324018.ref030","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28020776","article-title":"Evaluation of free online admet tools for academic or small biotech environments","volume":"28","author":"J Dulsat","year":"2023","journal-title":"Molecules"},{"key":"pone.0324018.ref031","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"G Xiong","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pone.0324018.ref032","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-019-2745-x","article-title":"Intraperitoneal route of drug administration: should it be used in experimental animal studies?","volume":"37","author":"A Al Shoyaib","year":"2020","journal-title":"Pharm Res"},{"issue":"6","key":"pone.0324018.ref033","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1124\/dmd.121.000428","article-title":"The nonclinical disposition and pharmacokinetic\/pharmacodynamic properties of N-acetylgalactosamine-conjugated small interfering RNA are highly predictable and build confidence in translation to human","volume":"50","author":"R McDougall","year":"2022","journal-title":"Drug Metab Dispos"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0345218","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000}}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0324018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T13:28:51Z","timestamp":1748525331000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0324018"}},"subtitle":[],"editor":[{"given":"Sajjad","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0324018","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]}}}